Cargando...
The revival of CpG oligonucleotide-based cancer immunotherapies
The promising results of clinical trials using immune checkpoint inhibitors revived interests in cancer immunotherapy. However, it also became apparent that efficacy of immune checkpoint blockade can benefit from combining it with immunostimulatory strategies. Here, we review prior and re-emerging a...
Gardado en:
| Publicado en: | Contemp Oncol (Pozn) |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Termedia Publishing House
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5885070/ https://ncbi.nlm.nih.gov/pubmed/29628795 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2018.73887 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|